Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries
Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries have?
Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries has 58 citations in the OpenAlex counts ScholarIQ stores.
When was Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries published?
Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries has 2001 year in the ScholarIQ index.
What is the open-access status of Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries?
Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries has closed oa status in the ScholarIQ index.
What is the DOI of Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries?
The DOI for Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries is on the source record.
What is the PMID of Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries?
The PMID for Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries is on the source record.
What is the OpenAlex record for Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries?
The OpenAlex for Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries is on the source record.